chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I immediately had dizziness and felt weak and nauseous. 5 minutes later the roof of my mouth started numbing and my left arm started hurting. I waited 30 min before leaving the pharmacy. Next day I h; I immediately had dizziness and felt weak and nauseous. 5 minutes later the roof of my mouth started numbing and my left arm started hurting. I waited 30 min before leaving the pharmacy. Next day I h; I immediately had dizziness and felt weak and nauseous. 5 minutes later the roof of my mouth started numbing and my left arm started hurting. I waited 30 min before leaving the pharmacy. Next day I h; I immediately had dizziness and felt weak and nauseous. 5 minutes later the roof of my mouth started numbing and my left arm started hurting. I waited 30 min before leaving the pharmacy. Next day I h; severe pain in my arm; Chills and fever.; Chills and fever.; Panic attack due to severe anxiety; Panic attack due to severe anxiety; This is a spontaneous report from a contactable consumer (patient). A 26-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EN6204 6/21), via an unspecified route of administration in arm left on 18Mar2021 (at the age of 26-year-old) as a dose 1, single for COVID-19 immunization. The patient's medical history and concurrent conditions were reported as none. The patient's concomitant medications received within 2 weeks of vaccination included Vitamin C, Tylenol. It was reported that, the patient was not pregnant at time of vaccination. Allergies to medications, food or other products was reported as no. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, has the patient been tested for COVID-19 was reported as no. On 18Mar2021 at 16:00, the patient immediately had dizziness and felt weak and nauseous. 5 minutes later the roof of her mouth started numbing and her left arm started hurting. Stated that, she waited 30 min before leaving the pharmacy. Stated that, next day, had severe pain in her arm. Chills and fever. A panic attack due to severe anxiety that lasted about an hour. Treatment received for the events included self-treated with Tylenol, Theraflu and Aspirin. The outcome of the events was recovered on an unspecified date in 2021.  Information on the lot/batch number has been requested. Follow-up attempts completed. No further information expected.
pt says he had a pounding headache feeling like he had the flu.  He had sweats, low grade fever, dry cough, nausea and chills.  These symptoms lasted about 24 hours.
Within half an hour of receiving the flu shot, I experienced pneumonia like symptoms with restricted breathing, my throat swelled and ached, my eyes turned bloodshot, my mouth began to burn, and my tissues began to swell.  I suspect I was allergic to the shot, perhaps there was thimerosal in it.  12 hours later, the pneumonia and restricted breathing were gone, but I experienced painful bloodshot eyes, swelling of hands and feet, gastric distress, and mouth burn and intense thirst.
This spontaneous report was received from a registered nurse who reported that an unspecified patient on an unspecified date was vaccinated with ZOSTAVAX (lot#J014812, expiry date: 20-FEB-2015; dose and route not reported) that was stored at -5C for six hours (temperature outside of the prescribing information). No adverse events were reported. Additional information is not expected.
Seizure; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 48-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 09Dec2022 at 16:30 as dose 4 (booster), single (Lot number: G33274) at the age of 48 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient has no known allergies. The patient did not receive any other vaccines within 4 weeks prior vaccination and had not been diagnosed with COVID-19 prior vaccination. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTUERER UNKNOWN), for Covid-19 immunization; Covid-19 vaccine (DOSE 2; MANUFACTUERER UNKNOWN), for Covid-19 immunization; Covid-19 vaccine (DOSE 3 (BOOSTER); MANUFACTUERER UNKNOWN), for Covid-19 immunization. The following information was reported: SEIZURE (hospitalization, medically significant, life threatening) with onset 02Jan2023, outcome "unknown". The patient was hospitalized for seizure (hospitalization duration: 2 day(s)). The event "seizure" required emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (02Jan2023) Negative, notes: Covid test post vaccination: Nasal Swab. Therapeutic measures were taken as a result of seizure.
heart palpitation; Heart rate went as high as 160; It was very scary when she started having side effects to COVID; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (heart palpitation), HEART RATE INCREASED (Heart rate went as high as 160) and ADVERSE EVENT (It was very scary when she started having side effects to COVID) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PALPITATIONS (heart palpitation), HEART RATE INCREASED (Heart rate went as high as 160) and ADVERSE EVENT (It was very scary when she started having side effects to COVID). At the time of the report, PALPITATIONS (heart palpitation), HEART RATE INCREASED (Heart rate went as high as 160) and ADVERSE EVENT (It was very scary when she started having side effects to COVID) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Just about 2-3 weeks after vaccination at 11/22/2021, her first symptom is weight lost, very thristy and appears skinnier than before, by the time 12/27 when checking her weight lost she is loosing 0.5lb every day, brought to PCP then later sent to hospital, blood sugar measured > 440 and immediately hospitalized eventually diagnosed as type 1 diabetes. She is now treated with multiple daily injection of insulin in order to keep her glucose level within range.
missed the second dose of GARDASIL 9 today; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, drug reactions, allergies, medical history, and concomitant therapies provided.      On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 1 dose (strength, route, lot # and expiration date were not reported) for prophylaxis. On 16-DEC-2020, the patient that missed the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) due to the schedule of a COVID 19 vaccine next week (inappropriate schedule of vaccine administered). The patient was told that they could not receive any other vaccines 2 weeks prior or 2 weeks after the injection of the COVID 19 vaccine.
big bright feverish red spot the size of an orange @ inj site;whole body ached for 2-3 days;very painful & stiff up around shoulder, down arm, down into armpit & chest area;
Headache and muscle weakness developed a little less than 24 hours later. At about 26 hours, mild nausea developed along with stomach cramps. A fever of 101 lasted through much of the night. The fever was around 100 the second day, and resolved by the morning of the third day. The headache was mild throughout, and lasted about 4 days. The nausea was off and on from about 26-48 hours post shot.  Weakness improved but persisted for about a week.
STRONG HEADACHE; CRAMPS IN HAND; ARM PAIN; This spontaneous report received from a patient via a company representative concerned a 48 year old male. The patient's height, and weight were not reported. The patient's past medical history included thyroid removed.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unk) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Concomitant medications included levothyroxine sodium. On APR-2021, the subject experienced cramps in hand. On APR-2021, the subject experienced arm pain. On 12-APR-2021, the subject experienced strong headache. Treatment medications included: acetylsalicylic acid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from cramps in hand, and arm pain on APR-2021, and was recovering from strong headache. This report was non-serious.
Pfizer-BioNTech COVID-19 Vaccine EUA. 1st dose. Injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, nausea, vomiting and feeling unwell. Took 2 extra-strength Tylenol at 12:15 pm on 5/9/21. I vomited them up less than a half-hour later. Also vomited a second time an hour later. Started feeling symptoms on 5/9/21 at 1 am and lasted a little over 24 hours. On 5/10/21, symptoms are gone except for tiredness. I tested positive for COVID-19 twice. First time was 11/17/20 - 12/7/20. Recovered fully. Had COVID-19 a second time on 3/20/21. This time a mild case with symptoms lasting only 4-5 days.
Grávida 2. EDD:7/15/21.  Numbness/tingling to face  for about 45 min.
After shots, patient returned within a few minutes with hives on face, and small papules and swelling of cheeks and lips.  No swelling of tongue.  Occasional cough.  Lungs clear.  Given BENADRYL and resolved.
This spontaneous report was received from a physician regarding a patient of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of PNEUMOVAX23 (dose, route of administration, lot # and expiration date were not reported). The dose of PNEUMOVAX23 was administered after being transported on dry ice for 15 minutes on an unspecified date. The reported was unable to provided a specific temperature that the PNEUMOVAX23 was stored at during the transport. There was no adverse event reported. Additional information is not expected as the physician did not wish to be contacted.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 24-SEP-2012, the patient was inoculated with ZOSTAVAX by a physician as recommended for routine adult health maintenance for the long-term prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 05-AUG-2016, the patient was treated by the same physician for the onset of a severe vesicular rash which was diagnosed as herpes zoster. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Loss of vision (L) eye. Superior half of vision (L) eye (L) optic neuropathy. Temporal Artery biopsy, IV steroids.
chills; body aches; fever of 102.9; extreme weakness; dizzy; This is a spontaneous report from a contactable consumer reported for himself. This 78-year-old male patient received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration at right arm on 22Jan2021 12:00 PM at single dose for covid-19 immunisation. Medical history included Seizures, low white cell count, enlarged prostate and COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. The patient had no allergies to medications, food, or other products. Concomitant medications included any other medications the patient received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 24Jan2021 08:00 AM (reported as 18 hours after injection), the patient experienced chills, body aches, fever of 102.9, extreme weakness, dizzy. At 4 am on 25Jan2021 the fever broke and now he was ok. No treatment received for the adverse event. Outcome of the events chills, body aches, extreme weakness and dizzy was recovered on an unspecified date, of the event fever of 102.9 was recovered on 25Jan2021. Since the vaccination, the patient had not been tested for COVID-19. Seriousness criteria was reported as non-serious.   Information on the lot/batch number has been requested.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Information regarding relevant medical history, concurrent condition and concomitant medications were not reported. On 12-DEC-2016, the patient was vaccinated with an expired dose of ZOSTAVAX (subcutaneous, lot # L032402, expiration date 26-NOV-2016, 0.65 ml) for prophylaxis. No symptoms reported.     Additional information has been requested.
body aches; I had fever; severe chills; diarrhea; nausea; headache; hung over; stiff neck; it prevented me from sleeping; This is a spontaneous report from a contactable consumer. A 25-year-old non-pregnant female received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number/batch number: 59267100001, expiration date: unknown), via intramuscular route of administration in the left arm on 27Jan2021 at 09:00 (at the age of 25-year-old) as 2nd dose, single dose for COVID-19 immunization. Medical history included asthma. Patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included escitalopram, IUD. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number/batch number: 59267100001, expiration date: unknown), via intramuscular route of administration in the left arm on 06Jan2021 at 02:00 as a single dose for COVID-19 immunization. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unspecified date in Jan2021, about 18 hours after the 2nd dose (1 AM), the patient experienced fever, severe chills, diarrhea, nausea, headache, body aches, and I was prevented from sleeping then it lasted about four hours before she got back to sleep. She woke up with a headache, stiff neck and generally felt "hung over" the next day. Advil was relieving at this point. The outcome of all the events was recovered.  Follow-up attempts are completed. No further information is expected.
Completed 2 dose vaccination series on 1/30/21 w/ Moderna Vaccine. Admitted 7/28/21 to Medical Center w/ complaints of weakness, body aches, dry cough. COVID PCR+ on 7/28. Also patient in atrial fibrillation. So far treated w/ dexamethasone, remdesivir x 1, vitamin D, zinc, vitamin C; O2 has improved from 3L NC to room air (sat 92-94%).
I did not have a reaction to the vaccine. I tested positive for COVID-19 on 03/17/2023. I went to a clinic and got a prescription for PAXLOVID and something for the cough. I had no trouble with the medication and tolerated it well. As of today, I feel that I get tired easily. I had a terrible cough the first day and I lost my appetite while having COVID-19.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 25-FEB-2014, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) at a pharmacy, as recommended for routine adult health maintenance and for the long-term prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster or shingles. On an unknown date in 2016, the patient was treated by a physician for the onset of a vesicular rash, which was diagnosed as herpes zoster or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering and other damages. Additional information has been requested.
Significant pain at injection site that radiates. Feels like an intense muscle cramp. Unable to put hand behind head without intense pain.
Headache, Myalgia, Arthralgia, chills, warm flushes, light sensitivity Narrative:  Pt experienced arthralgia, chills, warm flushes, headache, light sensitivity myalgia on same day after received covid vaccine. Pt treated with Tylenol PM 650 mg PO, Nyquil cold an flu caps PO
Arexvy to patient that was stored at 30.308F x 20 hours; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in a 64-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 3AK2K, expiry date 09-DEC-2024) for prophylaxis.   On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced incorrect storage of drug (Verbatim: Arexvy to patient that was stored at 30.308F x 20 hours).  The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK Receipt Date: 06-SEP-2023 The vaccine was exposed to 30.308 degree Fahrenheit for 20 hours, which led to incorrect storage of drug. The reporter did not consent to follow up.
Patient had headache, chills, fever, shaking, muscle aches, nausea and weakness within 24 hours
diarrhea; heat flashes; 7-8 blisters on the inside of his lower lip; sweats; was not eating; real bad body aches; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), HOT FLUSH (heat flashes), LIP BLISTER (7-8 blisters on the inside of his lower lip), HYPERHIDROSIS (sweats) and EATING DISORDER SYMPTOM (was not eating) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A and 08B21AHAN) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Congestive heart failure in January 2020.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced DIARRHOEA (diarrhea), HOT FLUSH (heat flashes), LIP BLISTER (7-8 blisters on the inside of his lower lip), HYPERHIDROSIS (sweats), EATING DISORDER SYMPTOM (was not eating) and MYALGIA (real bad body aches). At the time of the report, DIARRHOEA (diarrhea), HOT FLUSH (heat flashes), LIP BLISTER (7-8 blisters on the inside of his lower lip), HYPERHIDROSIS (sweats), EATING DISORDER SYMPTOM (was not eating) and MYALGIA (real bad body aches) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Apr-2021, Blood pressure measurement: 160/128 mmHg (High) Blood Pressure increased. On 23-Apr-2021, Heart rate: 77 (normal) 77 per minute. On 23-Apr-2021, Oxygen saturation: 97 (normal) 97 Percent.         The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) was not applicable.  No relevant concomitant medications were reported.   Treatment medication include rinse his mouth with warm water and salt .   This case was linked to US-MODERNATX, INC.-MOD-2021-092048 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Outcome of the events was updated from Unknown to Recovered.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-092048:Crosse linked
Immediately following vaccine I had a metallic taste in my mouth and my arm felt a tad heavier than the right.  I was fine until I woke up 11pm or so with body aches, fever of 100.8 or so, headache, stomach craps and was extremely tired.  These side effects went on all of Friday to where I missed work with all symptoms and fever reaching over 102. (I didn't have that when I had Covid.) Saturday and Saturday evening were much of the same but the fever came down to 99.5 or so with improvement on headache and body aches.  Slept the better part of Friday through Sunday morning when I had returned to fever free and mostly myself less some mild sleepiness.
Crohn's disease of small intestine with other complication. Patient was found to have stricture and partial obstruction proximal to her ileorectal anastomosis. She presented 10/21 for resection of ileorectal anastomosis and creation of new ileorectal anastomosis with diverting loop ileostomy. Post operatively, she did well. Hospital admission within 6 weeks of receiving the COVID vaccine.
Pt started shivering and felt cold about 1-2min after vaccine administered. No LOC or change in MS, no sob or other sx. Pt covered with warm blanket, and rested at our facility for about 1/2 hour. She left after sx completely resolved and had no further difficulties
24 hours after injection she is tingling and numbness of left leg coming from her foot up to knee; 24 hours after injection she is tingling and numbness of left leg coming from her foot up to knee; This spontaneous case was reported by a pharmacist and describes the occurrence of PARAESTHESIA (24 hours after injection she is tingling and numbness of left leg coming from her foot up to knee) and HYPOAESTHESIA (24 hours after injection she is tingling and numbness of left leg coming from her foot up to knee) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (24 hours after injection she is tingling and numbness of left leg coming from her foot up to knee) and HYPOAESTHESIA (24 hours after injection she is tingling and numbness of left leg coming from her foot up to knee). At the time of the report, PARAESTHESIA (24 hours after injection she is tingling and numbness of left leg coming from her foot up to knee) and HYPOAESTHESIA (24 hours after injection she is tingling and numbness of left leg coming from her foot up to knee) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment drug was not provided.  no concomitant medications was provided.
Fever 101, sweats, tired and drained. Feeling like my head is in a fog. No treatment.